TD-1607 MAD Study in Healthy Subjects

NCT01949103 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections
Bacterial Infections

Interventions

DRUG: TD-1607
DRUG: Placebo

Sponsor

Theravance Biopharma